Patents by Inventor Steven K. Jacobs
Steven K. Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11988172Abstract: An ignition safety device (ISD) used in an ignition system of a missile is configured to selectively control the ignition of two or more pulses or stages of a rocket motor propulsion system, based on a flight profile mode selection of a flight velocity mode, in which the missile is configured to travel at an optimized flight velocity, or a flight distance mode, in which the missile is configured to travel an optimized flight distance. The ISD is configured to selectively ignite the pulses or stages substantially simultaneously upon selection of the flight velocity mode, or in a delayed sequential manner upon selection of the flight distance mode. The ISD is also configured to selectively inhibit the delayed sequential ignition of the pulses or stages in the event of incidental ground or water impact of the missile after ignition of the primary pulse or stage.Type: GrantFiled: November 19, 2020Date of Patent: May 21, 2024Assignee: Raytheon CompanyInventors: Shawn Coffee, Saifur Ahmed, Steven D. Jacob, Thomas K. Harward
-
Patent number: 9632530Abstract: A deck supports depressable keys. The keys can be resiliently biased to a raised state. A display panel can be pivotally coupled to the deck for movement between a deployed position and a closed position. A retraction mechanism comprises a retraction frame and a retraction drive. The retraction frame is translatable between a releasing position along the depressable keys to actuate the depressable keys to the raised state and a retracting position moving to move the depressable keys to the retracted state. The retraction drive translates the retraction frame towards the retracting position in response to pivoting of the display panel towards the closed position.Type: GrantFiled: August 26, 2013Date of Patent: April 25, 2017Assignee: Hewlett-Packard Development Company, L.P.Inventor: Steven K Jacobs
-
Patent number: 9489017Abstract: A retraction mechanism moves a depressable key downward along a sloped surface from a raised state to a retracted state relative to a deck.Type: GrantFiled: August 26, 2013Date of Patent: November 8, 2016Assignee: Hewlett-Packard Development Company, L.P.Inventor: Steven K Jacobs
-
Publication number: 20160170451Abstract: A retraction mechanism moves a depressable key downward along a sloped surface from a raised state to a retracted state relative to a deck.Type: ApplicationFiled: August 26, 2013Publication date: June 16, 2016Inventor: STEVEN K JACOBS
-
Publication number: 20160161987Abstract: A deck supports depressable keys. The keys can be resiliently biased to a raised state. A display panel can be pivotally coupled to the deck for movement between a deployed position and a closed position. A retraction mechanism comprises a retraction frame and a retraction drive. The retraction frame is translatable between a releasing position along the depressable keys to actuate the depressable keys to the raised state and a retracting position moving to move the depressable keys to the retracted state.Type: ApplicationFiled: August 26, 2013Publication date: June 9, 2016Inventor: Steven K. JACOBS
-
Patent number: 9149271Abstract: A device and method for treatment of hemorrhoids, in which the devices includes: a housing insertable into the rectum; a tissue port configured to receive a tissue segment containing at least a portion of a hemorrhoidal blood vessel; opposing needle chambers including at least one pair of corresponding needles coupled by a suture in which the pair of corresponding needles are substantially opposite to one another and in an active position substantially aligned with the tissue segment; a needle driver that advances the pair of corresponding needles through the tissue segment to encircle a portion of the hemorrhoidal blood vessel with the suture, thereby ligating the hemorrhoidal blood vessel; and an actuator coupled to at least one of the needle chambers that actuates the needle chambers such that another pair of corresponding needles is in the active position.Type: GrantFiled: November 22, 2010Date of Patent: October 6, 2015Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD, JR. UNIVERSITYInventors: Jacob S. Brenner, Gregory A. Magee, Angelo F. Szychowski, Gaurav Krishnamurthy, Steven K. Jacobs
-
Publication number: 20120130403Abstract: A device and method for treatment of hemorrhoids, in which the devices includes: a housing insertable into the rectum; a tissue port configured to receive a tissue segment containing at least a portion of a hemorrhoidal blood vessel; opposing needle chambers including at least one pair of corresponding needles coupled by a suture in which the pair of corresponding needles are substantially opposite to one another and in an active position substantially aligned with the tissue segment; a needle driver that advances the pair of corresponding needles through the tissue segment to encircle a portion of the hemorrhoidal blood vessel with the suture, thereby ligating the hemorrhoidal blood vessel; and an actuator coupled to at least one of the needle chambers that actuates the needle chambers such that another pair of corresponding needles is in the active position.Type: ApplicationFiled: November 22, 2010Publication date: May 24, 2012Inventors: Jacob S. Brenner, Gregory A. Magee, Angelo F. Szychowski, Gaurav Krishnamurthy, Steven K. Jacobs
-
Patent number: 6997861Abstract: The invention described herein comprises a method of treating a subject having a disorder characterized by the presence of one or more tumors comprising inserting a miniaturized concentrated neutron emitting source into said tumor(s) for a time sufficient to irradiate the cells of the tumor(s). The invention method can be employed in the treatment of both malignant and non-malignant tumors and is especially useful in the treatment of malignant tumors found in the brain, prostate, and other internal organs. A preferred neutron source is californium-252. The majority of the tumor can be surgically removed prior to insertion of the neutron emitting source. In a further embodiment of the invention, a neutron capture compound can be localized to the cells of the tumor prior to insertion of the miniaturized neutron emitting source in order to augment the effects of neutron therapy.Type: GrantFiled: January 27, 2004Date of Patent: February 14, 2006Inventors: David Halpern, Steven K. Jacobs
-
Publication number: 20040184988Abstract: The invention described herein comprises a method of treating a subject having a disorder characterized by the presence of one or more tumors comprising inserting a miniaturized concentrated neutron emitting source into said tumor(s) for a time sufficient to irradiate the cells of the tumor(s). The invention method can be employed in the treatment of both malignant and non-malignant tumors and is especially useful in the treatment of malignant tumors found in the brain, prostate, and other internal organs. A preferred neutron source is californium-252. The majority of the tumor can be surgically removed prior to insertion of the neutron emitting source. In a further embodiment of the invention, a neutron capture compound can be localized to the cells of the tumor prior to insertion of the miniaturized neutron emitting source in order to augment the effects of neutron therapy.Type: ApplicationFiled: January 27, 2004Publication date: September 23, 2004Inventors: David Halpern, Steven K. Jacobs
-
Patent number: 6685619Abstract: The invention described herein comprises a method of treating a subject having a disorder characterized by the presence of one or more tumors comprising inserting a miniaturized concentrated neutron emitting source into said tumor(s) for a time sufficient to irradiate the cells of the tumor(s). The invention method can be employed in the treatment of both malignant and non-malignant tumors and is especially useful in the treatment of malignant tumors found in the brain, prostate, and other internal organs. A preferred neutron source is californium-252. The majority of the tumor can be surgically removed prior to insertion of the neutron emitting source. In a further embodiment of the invention, a neutron capture compound can be localized to the cells of the tumor prior to insertion of the miniaturized neutron emitting source in order to augment the effects of neutron therapy.Type: GrantFiled: November 8, 2001Date of Patent: February 3, 2004Assignee: Isotron, Inc.Inventors: David Halpern, Steven K. Jacobs
-
Publication number: 20020058852Abstract: The invention described herein comprises a method of treating a subject having a disorder characterized by the presence of one or more tumors comprising inserting a miniaturized concentrated neutron emitting source into said tumor(s) for a time sufficient to irradiate the cells of the tumor(s). The invention method can be employed in the treatment of both malignant and non-malignant tumors and is especially useful in the treatment of malignant tumors found in the brain, prostate, and other internal organs. A preferred neutron source is califormium-252. The majority of the tumor can be surgically removed prior to insertion of the neutron emitting source. In a further embodiment of the invention, a neutron capture compound can be localized to the cells of the tumor prior to insertion of the miniaturized neutron emitting source in order to augment the effects of neutron therapy.Type: ApplicationFiled: November 8, 2001Publication date: May 16, 2002Inventors: David Halpern, Steven K. Jacobs
-
Patent number: 6319189Abstract: A method of treating a subject having a disorder characterized by a tumor performed by inserting a miniaturized concentrated neutron emitting source into the tumor to irradiate the cells of the tumor. The method is useful in treating malignant and non-malignant tumors and is especially useful in the treating of tumors of the brain, prostate, cervix and other internal organs. A preferred neutron source is californium-252. The tumor may be surgically treated prior to insertion of the neutron emitting source. A neutron capture compound may be localized to the cells of the tumor prior to insertion of the source to augment the effects of neutron therapy.Type: GrantFiled: September 13, 1999Date of Patent: November 20, 2001Assignee: Isotron, Inc.Inventors: David Halpern, Steven K. Jacobs